{
    "pfizerFacts": [
      {
        "description": "Approval of Pfizer/BioNTech vaccine in UK",
        "title": "UK Approval",
        "date": "2020/12/02"
      },
      {
        "description": "Approval of Pfizer/BioNTech vaccine in Canada",
        "title": "Canada Approval",
        "date": "2020/12/09"
      },
      {
        "description": "Sandra Lindsay, a critical care nurse from Northwell Long Island Jewish Medical Center was the first vaccinated in New York",
        "title": "1st Pfizer Vaccine shot in US",
        "date": "2020/12/14"
      },
      {
        "description": "Approval of Pfizer/BioNTech vaccine in EU",
        "title": "EU Approval",
        "date": "2020/12/21"
      },    
      {
        "description": "Pfizer/BioNTech announced that their vaccine is highly effective in adolescents 12 to 15 years old",
        "title": "Highly effective in adolescents",
        "date": "2021/03/31"
      },
      {
        "description": "Call for fast-track approval of Pfizer/BioNTech vaccine by India",
        "title": "India Approval Call",
        "date": "2021/04/14"
      }
    ],
    "pfizerTimeline": [
      {
        "description": "Pfizer (along with Moderna) uses a new vaccine approach involving messenger RNA",
        "title": "Pfizer/BioNTech Trial",
        "start": "2020/03/29",
        "end": "2020/11/29",
        "color": "#00a950"
      },
      {
        "description": "Pfizer (along with Moderna) uses a new vaccine approach involving messenger RNA",
        "title": "Test",
        "start": "2020/03/29",
        "end": "2020/11/29",
        "color": "#00a950"
      },
      {
        "description": "Pfizer was the first company to report positive phase 3 clinical data",
        "title": "Review",
        "start": "2020/11/29",
        "end": "2020/12/11",
        "color": "#00a950"
      },
      {
        "description": "Dosage - 2 doses, 3 weeks apart",
        "title": "US Approval",
        "start": "2020/12/11",
        "end": "2021/06/30",
        "color": "#00a950"
      }
    ],
    "otherVaccines": [
      {
        "description": "Moderna (along with Pfizer) uses a new vaccine approach involving messenger RNA",
        "title": "Moderna trials start",
        "date": "2020/07/27"
      },
      {
        "description": "Submitted for review",
        "title": "Moderna Review",
        "date": "2020/11/30"
      },
      {
        "description": "Dosage - 2 doses, 4 weeks apart",
        "title": "Moderna US Approval",
        "date": "2020/12/18"
      },
      {
        "description": "The vaccine is being developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson",
        "title": "Johnson and Johnson trials start",
        "date": "2020/09/07"
      },
      {
        "description": "Trial shows 66% efficacy",
        "title": "Johnson and Johnson Review",
        "date": "2021/01/29"
      },
      {
        "description": "Dosage - 1 dose",
        "title": "Johnson and Johnson US Approval",
        "date": "2021/02/27"
      },
      {
        "description": "Vaccine developed by a small biotech firm in US",
        "title": "Novavax trials start",
        "date": "2020/09/28"
      },
      {
        "description": "Trial shows about 90% efficacy",
        "title": "Novavax Review",
        "date": "2021/01/28"
      },
      {
        "description": "US pauses J&J vaccine over clot reports",
        "title": "Johnson and Johnson vaccine paused",
        "date": "2021/04/13"
      }
    ]
   }